House OKs prescription drug imports

WASHINGTON – The House voted Tuesday to allow Americans to buy prescription drugs from Canada and other countries at prices lower than found in the United States, but the provision’s prospects are dim to become law this year.

The measure, approved as part of a $16.8 billion bill to fund the Agriculture Department and the Food and Drug Administration for next year, would prohibit the FDA from spending money to enforce its prohibition on imports of FDA-approved drugs.

A subcommittee put it into the bill last month at the instigation of Rep. Marcy Kaptur, D-Ohio. The bill itself passed the House on Tuesday by a 389-31 vote.

Supporters said it would allow Americans safe access to medications at prices often one-third lower than those in the United States because of government price controls in other countries.

The provision is not expected to remain in the final spending bill to be reconciled later by House and Senate negotiators, a Republican staff member said.

A nearly identical plan was passed by the House last year, only to be removed later in House-Senate negotiations.

The White House budget office opposed the measure in a statement Tuesday. “It would be virtually impossible for the FDA to verify that drugs being imported are indeed FDA-approved and not counterfeit,” the statement said.

It did not threaten a presidential veto, however, saying the administration supported the farm bill itself..